Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lunabell, widely known by its brand name The Pill Club, was a prominent digital health company specializing in women's reproductive healthcare. The company provided an end-to-end platform that combined telehealth consultations with a mail-order pharmacy to deliver birth control and other wellness products directly to patients. By streamlining the prescription and insurance process, Lunabell aimed to increase access to contraception and reproductive health services across the United States. In 2023, following a rebranding to Favor and a subsequent bankruptcy filing, the company's assets and patient base were acquired by Thirty Madison.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lunabell.